Megan Daly, Md
Clinical trials sponsored by Megan Daly, Md, explained in plain language.
-
New combo therapy shows promise for hard-to-treat lung cancer
Disease control CompletedThis study tested a combination of a cancer vaccine (TG4010) and an immunotherapy drug (nivolumab) in 13 people with advanced non-small cell lung cancer who had already received other treatments. The goal was to see if the combination could shrink tumors or stop them from growing…
Phase: PHASE2 • Sponsor: Megan Daly, MD • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New combo therapy shows promise for inoperable lung cancer
Disease control CompletedThis early-stage trial tested a combination of an immunotherapy drug (atezolizumab) and precise radiation therapy (SBRT) in 20 people with stage I non-small cell lung cancer who couldn't have surgery. The main goal was to find the safest dose and check for side effects. Researche…
Phase: PHASE1 • Sponsor: Megan Daly, MD • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC